- Home
- ORLA vs KYMR Comparison
ORLA vs KYMR Comparison
Compare ORLA & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORLA
- KYMR
- Stock Information
- Founded
- ORLA 2007
- KYMR 2015
- Country
- ORLA Canada
- KYMR United States
- Employees
- ORLA N/A
- KYMR N/A
- Industry
- ORLA Precious Metals
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- ORLA Basic Materials
- KYMR Health Care
- Exchange
- ORLA Nasdaq
- KYMR Nasdaq
- Market Cap
- ORLA 3.8B
- KYMR 3.1B
- IPO Year
- ORLA N/A
- KYMR 2020
- Fundamental
- Price
- ORLA $11.56
- KYMR $46.46
- Analyst Decision
- ORLA Buy
- KYMR Strong Buy
- Analyst Count
- ORLA 2
- KYMR 15
- Target Price
- ORLA $14.50
- KYMR $58.53
- AVG Volume (30 Days)
- ORLA 1.4M
- KYMR 618.6K
- Earning Date
- ORLA 11-11-2025
- KYMR 10-30-2025
- Dividend Yield
- ORLA N/A
- KYMR N/A
- EPS Growth
- ORLA N/A
- KYMR N/A
- EPS
- ORLA 0.07
- KYMR N/A
- Revenue
- ORLA $596,487,000.00
- KYMR $44,711,000.00
- Revenue This Year
- ORLA $170.92
- KYMR $58.45
- Revenue Next Year
- ORLA $23.64
- KYMR N/A
- P/E Ratio
- ORLA $144.65
- KYMR N/A
- Revenue Growth
- ORLA 116.83
- KYMR N/A
- 52 Week Low
- ORLA $3.81
- KYMR $19.45
- 52 Week High
- ORLA $12.83
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- ORLA 59.24
- KYMR 61.95
- Support Level
- ORLA $10.56
- KYMR $42.71
- Resistance Level
- ORLA $11.99
- KYMR $44.43
- Average True Range (ATR)
- ORLA 0.43
- KYMR 1.96
- MACD
- ORLA 0.07
- KYMR 0.48
- Stochastic Oscillator
- ORLA 74.59
- KYMR 97.56
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Musselwhite gold mine project located in Ontario and the South Railroad projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.